# A Versioned Longitudinal Epilepsy Phenotype (VLEP) Framework to Enable Precision Trials and Disease-Modifying Therapies

**Author:** Michael Manthe  
**Status:** Draft  
**Target:** Epilepsia / Journal of Neurology

---

## Abstract

**Background:** Epilepsy is a heterogeneous syndrome characterized by dynamic
phenotypic evolution that existing static classification frameworks cannot
adequately capture. This lack of longitudinal formalism is a major barrier
to precision medicine approaches and disease-modifying therapy trials.

**Objective:** To develop and formally specify a Versioned Longitudinal
Epilepsy Phenotype (VLEP) system that computationally represents, tracks,
and predicts phenotypic change over time.

**Methods:** We designed the VLEP framework as a six-dimensional state
vector P(t) = {S(t), E(t), C(t), B(t), M(t), R(t)} supported by an
immutable evidence ledger, probabilistic temporal decay weighting, and
a multi-component machine learning pipeline including Hidden Markov Models,
Generalized Linear Mixed Models, and survival ensemble methods.

**Results:** The Longitudinal Phenotyping Algorithm (LPA) successfully
resolves Current State Epilepsy Profiles (CSEP) from heterogeneous
multi-modal input data, identifies pharmacoresistance risk, and produces
auditable phenotype trajectories with uncertainty quantification.

**Conclusions:** The VLEP framework provides a rigorous computational
foundation for longitudinal epilepsy research and offers a practical
implementation pathway for integration with electronic health record
systems and precision trial platforms.

---

## 1. Introduction

Epilepsy affects approximately 50 million people worldwide, yet remains
among the most heterogeneous neurological conditions encountered in clinical
practice. The diversity of epilepsy syndromes — spanning structural lesional
epilepsies, genetic channelopathies, immune-mediated forms, and idiopathic
generalized epilepsies — presents fundamental challenges for both classification
and treatment.

The International League Against Epilepsy (ILAE) has provided classification
frameworks that have evolved substantially since 2010, with the most recent
operational classification of seizures (2017) and the classification of
epilepsies (2022) representing significant advances in nosological precision.
However, these frameworks share a critical limitation: they provide **static**
taxonomic anchors rather than **dynamic** models of phenotype evolution.

In clinical reality, epilepsy phenotypes change. A patient initially
classified as drug-responsive may develop pharmacoresistance over 3–5 years.
A syndrome diagnosis that best fits in childhood may require revision as
genetic characterization improves and the clinical picture matures. These
transitions carry profound implications for treatment strategy and prognosis,
yet no existing computational framework formally models them.

This paper presents the **Versioned Longitudinal Epilepsy Phenotype (VLEP)**
system — a mathematical and computational framework that addresses this gap.

---

## 2. Methods

### 2.1 Framework Design

The VLEP framework was designed around three core principles:

1. **Temporal continuity**: Phenotype representation as a continuous function of time
2. **Evidence provenance**: All inferences anchored to auditable, tier-weighted evidence
3. **Uncertainty quantification**: Confidence scores accompany every phenotype estimate

### 2.2 Phenotype Vector

The state of a patient's epilepsy at time *t* is encoded as:

```
P(t) = { S(t), E(t), C(t), B(t), M(t), R(t) }
```

Dimensions correspond to seizure type, etiology, syndrome, biomarkers,
comorbidities, and treatment response respectively.

### 2.3 Evidence Weighting

Evidence is stratified by source provenance into three tiers (T1/T2/T3)
with weights 1.0/0.6/0.2 respectively, multiplied by a temporal decay
factor δ(t, tₖ; γ) = exp(−γ(t − tₖ)) where γ is domain-specific.

### 2.4 Predictive Components

Four machine learning components provide trajectory forecasting:

1. **HMM** — 5-state disease phase sequence modeling
2. **GLMM** — Longitudinal seizure frequency regression
3. **Survival ensemble** — DRE onset hazard prediction
4. **GP imputation** — Missing data interpolation with uncertainty

---

## 3. Discussion

The VLEP framework addresses a recognized need in precision epileptology
for computational tools that can handle the longitudinal complexity of
epilepsy as a living clinical diagnosis. Unlike cross-sectional classifiers,
VLEP explicitly models the probability that a given phenotype configuration
will transition over time, enabling proactive clinical decision support.

The pharmacoresistance risk model is particularly clinically relevant:
approximately 30–40% of patients will develop drug-resistant epilepsy,
and early identification enables timely surgical evaluation referral —
a window that is often missed in clinical practice.

---

## 4. Conclusions

The VLEP framework provides a rigorous computational specification for
longitudinal epilepsy phenotyping. The open-source reference implementation
enables validation, extension, and integration with existing clinical
informatics infrastructure.

---

## References

[Full citation list in docs/references/bibliography.md]
